FDA’s Botox Warning Targets Websites With Unapproved Products



(MedPage Today) — The FDA sent 18 warning letters to websites that illegally market unapproved and misbranded botulinum toxin (Botox) products, the agency announced.
The letters were addressed to sites with names like cosmo-korea.com, derma-solution…



Source link : https://www.medpagetoday.com/publichealthpolicy/fdageneral/118329

Author :

Publish date : 2025-11-05 21:08:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version